Alexandria Real Estate Equities Secures $5 Billion Credit Extension

The amended agreement extends the maturity date of the facility from January 2030 to January 2032, provided the company utilizes two available six-month extension options. Beyond the timeline shift, the deal secures more favorable terms for the S&P 500 life science REIT, reducing the borrowing margin by 11 basis points to SOFR plus 0.725%.

Marc E. Binda, the company's chief financial officer, described the transaction as a method to prune the long-term cost of capital while maintaining a disciplined balance sheet. Citibank, N.A. acted as the administrative agent for the deal, leading a syndicate of financial institutions including BofA Securities, JPMorgan Chase, and Goldman Sachs. The extended capacity ensures Alexandria retains significant revolving credit to navigate market cycles across its various life science innovation clusters.